文献速递心脑血管急症儿科与产科急症

青少年运动相关脑震荡的血浆生物标志物研究

Plasma Biomarkers of Traumatic Brain Injury in Adolescents With Sport-Related Concussion.
PubMed 文献 · JAMA Netw Open · 2024-09-03
一句话结论青少年运动相关脑震荡后血浆GFAP、UCH-L1、NfL、t-tau与未损伤时存在差异,且受年龄和性别影响,支持其用于理解脑震荡神经病理。

这项前瞻性队列研究纳入849名10-18岁加拿大运动参与者,在赛季前(未损伤)和脑震荡后(≤72小时、1周、每两周直至医学许可重返赛场)采集血样,检测血浆GFAP、UCH-L1、NfL和t-tau。急性期(伤后0-3天)GFAP在女性和男性分别升高17.8%和17.1%,UCH-L1在女性升高43.4%,NfL在男性升高19.0%,t-tau在女性和男性分别降低22.9%和18.4%。伤后4-10天、11-28天及>28天所有标志物与未损伤组仍有差异。GFAP、NfL和t-tau与SCAT5症状评分相关;伤后28天以上较高GFAP与更早医学许可重返赛场相关(HR 4.78)。年龄和性别是重要考虑因素。

要点

  • 急性期(伤后0-3天)GFAP在女性升高17.8%(β=0.164,95%CI 0.064-0.263,P=.001),男性升高17.1%(β=0.157,95%CI 0.086-0.229,P<.001)。
  • 急性期UCH-L1在女性升高43.4%(β=0.361,95%CI 0.125-0.596,P=.003),NfL在男性升高19.0%(β=0.174,95%CI 0.087-0.261,P<.001)。
  • 急性期t-tau在女性降低22.9%(β=-0.260,95%CI -0.391至-0.130,P<.001),男性降低18.4%(β=-0.203,95%CI -0.300至-0.106,P<.001)。
  • 伤后28天以上较高GFAP与更早医学许可重返赛场相关(HR 4.78,95%CI 1.59-14.31,P=.01)。
  • 男性较女性GFAP低9.7%但UCH-L1高21.3%;年龄每增加1岁GFAP降低5.4%、t-tau降低5.3%。

适用人群与场景

  • 10-18岁加拿大运动参与者,来自高中和社区运动减少脑震荡及其后果监测研究(2019年9月至2022年11月),为便利样本。
  • 纳入有血样的849名参与者,其中695名未损伤(男性467名[67.2%],中位[IQR]年龄15.90[15.13-16.84]岁)和154名脑震荡(男性78名[51.0%],中位[IQR]年龄16.12[15.31-17.11]岁)。

研究设计与关键结果

  • 研究类型为前瞻性队列研究,纳入849名青少年运动参与者,采集1023份血浆标本,检测GFAP、UCH-L1、NfL和t-tau。
  • 急性期(伤后0-3天)与未损伤组相比:GFAP女性升高17.8%(β=0.164,95%CI 0.064-0.263,P=.001),男性升高17.1%(β=0.157,95%CI 0.086-0.229,P<.001);UCH-L1女性升高43.4%(β=0.361,95%CI 0.125-0.596,P=.003);NfL男性升高19.0%(β=0.174,95%CI 0.087-0.261,P<.001);t-tau女性降低22.9%(β=-0.260,95%CI -0.391至-0.130,P<.001),男性降低18.4%(β=-0.203,95%CI -0.300至-0.106,P<.001)。
  • 伤后4-10天、11-28天及>28天所有标志物与未损伤组相比仍有差异。
  • GFAP、NfL和t-tau在多个伤后时间区间与SCAT5症状评分相关。
  • 伤后28天以上较高GFAP与更早医学许可重返赛场相关(HR 4.78,95%CI 1.59-14.31,P=.01)。
  • 男性较女性GFAP低9.7%,但UCH-L1高21.3%;年龄每增加1岁GFAP降低5.4%、t-tau降低5.3%。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为年龄和性别是这些生物标志物走向临床验证时的关键考虑因素。
  • 作者认为血浆生物标志物支持继续用于理解脑震荡神经病理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Blood-based biomarkers may clarify underlying neuropathology and potentially assist in clinical management of adolescents with sport-related concussion (SRC).

OBJECTIVE: To investigate the association between SRC and plasma biomarkers in adolescents.

DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study in Canadian sport and clinic settings (Surveillance in High Schools and Community Sport to Reduce Concussions and Their Consequences study; September 2019 to November 2022). Participants were a convenience sample of 849 adolescent (ages 10-18 years) sport participants with blood samples. Data were analyzed from February to September 2023.

EXPOSURES: Blood collection and clinical testing preseason (uninjured) and post-SRC follow-ups (ie, ≤72 hours, 1 week, and biweekly until medical clearance to return to play [RTP]).

MAIN OUTCOMES AND MEASURES: Plasma glial fibrillary acidic protein (GFAP), ubiquitin c-terminal hydrolase-L1 (UCH-L1), neurofilament light (NfL), and total tau (t-tau) were assayed. Group-level comparisons of biomarker levels were conducted between uninjured and post-SRC intervals (postinjury day [PID] 0-3, 4-10, 11-28, and >28) considering age and sex as modifiers. Secondary analyses explored associations between biomarker concentrations and clinical outcomes (Sport Concussion Assessment Tool, Fifth Edition [SCAT5] symptom scores and time to RTP).

RESULTS: This study included 1023 plasma specimens from 695 uninjured participants (467 male participants [67.2%]; median [IQR] age, 15.90 [15.13-16.84] years) and 154 participants with concussion (78 male participants [51.0%]; median [IQR] age, 16.12 [15.31-17.11] years). Acute (PID 0-3) differences relative to uninjured levels were found for GFAP (female participants: 17.8% increase; β = 0.164; 95% CI, 0.064 to 0.263; P = .001; male participants: 17.1% increase; β = 0.157; 95% CI, 0.086 to 0.229; P < .001), UCH-L1 (female participants: 43.4% increase; β = 0.361; 95% CI, 0.125 to 0.596; P = .003), NfL (male participants: 19.0% increase; β = 0.174; 95% CI, 0.087 to 0.261; P < .001), and t-tau (female participants: -22.9%; β = -0.260; 95% CI, -0.391 to -0.130; P < .001; male participants: -18.4%; β = -0.203; 95% CI, -0.300 to -0.106; P < .001). Differences were observed for all biomarkers at PID 4 to 10, 11 to 28, and greater than 28 compared with uninjured groups. GFAP, NfL, and t-tau were associated with SCAT5 symptom scores across several PID intervals. Higher GFAP after 28 days post-SRC was associated with earlier clearance to RTP (hazard ratio, 4.78; 95% CI, 1.59 to 14.31; P = .01). Male participants exhibited lower GFAP (-9.7%), but higher UCH-L1 (21.3%) compared with female participants. Age was associated with lower GFAP (-5.4% per year) and t-tau (-5.3% per year).

CONCLUSIONS AND RELEVANCE: In this cohort study of 849 adolescents, plasma biomarkers differed between uninjured participants and those with concussions, supporting their continued use to understand concussion neuropathology. Age and sex are critical considerations as these biomarkers progress toward clinical validation.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Tabor JB, Penner LC, Galarneau JM, et al. Plasma Biomarkers of Traumatic Brain Injury in Adolescents With Sport-Related Concussion. JAMA Netw Open. 2024. PMID: 39235809. doi:10.1001/jamanetworkopen.2024.31959

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。